The identification of anti-NMDA receptor (NMDAR) encephalitis about 12 years ago made
it possible to recognise that some patients with rapidly progressive psychiatric symptoms
or cognitive impairment, seizures, abnormal movements, or coma of unknown cause, had
an autoimmune disease.